Miami, FL, United States
Miami, FL, United States

Time filter

Source Type

News Article | May 11, 2017
Site: www.prlog.org

Stylish and functional hotel design lets extended-stay guests thrive on the road -- The 105-suite Residence Inn by Marriott in Oklahoma City, Oklahoma is scheduled to open on Monday, May 22, 2017.  Located at 3151 Northwest Expressway, the all-suite Residence Inn Oklahoma City Northwest will operate as a Marriott franchise, managed by Champion Hotels of Oklahoma City, Oklahoma.Located 15 minutes from downtown Oklahoma City and 12 miles from Will Rogers World Airport, the Residence Inn Oklahoma City Northwest offers its guests convenient access to the Bricktown District, Boathouse District, Oklahoma City National Memorial, Remington Park, Lake Hefner Golf Course, Integris Baptist Hospital and the Oklahoma City Zoo. Rates vary depending on length of stay."We are pleased with the continued growth of Residence Inn hotels in the Oklahoma City area," said Diane Mayer, vice president and global brand manager, Residence Inn. "When on the road for an extended period, our guests need space to spread out, maintain their life's pace and restore their energy to help them maintain a healthy balance and routine while traveling. This new hotel offers them a seamless blend of modern style and functionality that allows them to settle in and thrive."Residence Inn properties are designed as all-suite hotels that offer studio, one-bedroom and two-bedroom suites. Guests looking for a revitalizing sleep experience will enjoy the hotel's plush mattresses and crisp linens, while guests focused on being productive will value their suite's large, well-lit work desk, ergonomic chair and complimentary high-speed Internet access. Designed for stays of five nights or more, each suite also has a fully-equipped kitchen with a coffeemaker, microwave oven and residential-sized appliances.The Residence Inn Oklahoma City Northwest's complimentary breakfast has a variety of great options, including specially made featured items. Guests can start their day off right with healthy food choices and, with a convenient to-go offering, can make sure they do not miss the most important meal of the day.Extending the feeling of comfortable living on the road, the Residence Inn Oklahoma City Northwest offers guests inviting and functional public spaces to relax or collaborate. Road warriors and families alike enjoy the hotel's grocery delivery service, complimentary Wi-Fi, 24-hour onsite food and beverage market, dry cleaning services, and onsite guest laundry room. The hotel's weeknight evening gatherings - the MIX offer a casual, relaxing environment where guests can be as social as they want, while enjoying premium beers and connection to local flavors. The hotel also maintains a business library where guests can fax, copy and print materials, and provides guests with an outdoor swimming pool, exercise room and meeting room.About Residence Inn by MarriottResidence Inn by Marriott is the global leader in the extended-stay lodging segment, with more than 700 properties located in 10 countries and territories. Designed for long stays, the brand offers spacious suites with separate living, working, and sleeping zones. Fully functional kitchens; grocery delivery service; 24-hour markets and complimentary breakfasts help guests maximize their time and thrive while they travel. The RI Mix evening events afford guests the opportunity to socialize and connect with the local community. Each Residence Inn offers free Wi-Fi in both public and guests spaces to ensure continuous connectivity while on the road. As a member of the Marriott International portfolio, Residence Inn is proud to participate in the industry's award-winning loyalty program, Marriott Rewards® which includes The Ritz-Carlton Rewards®. Members can now link accounts with Starwood Preferred Guest® at members.marriott.com for instant elite status matching and unlimited points transfer. For more information or reservations, visit residenceinn.marriott.com. For travel tips, the latest on the brand or to connect with other travelers, "like" Residence Inn on Facebook and follow @ResidenceInn on Twitter and Instagram.-------------------------------------Marriott International, Inc. is based in Bethesda, Maryland, USA, and encompasses a portfolio of more than 6,000 properties in 30 leading hotel brands spanning 122 countries and territories. Marriott operates and franchises hotels and licenses vacation ownership resorts. The company also operates award-winning loyalty programs: Marriott Rewards®, which includes The Ritz-Carlton Rewards®, and Starwood Preferred Guest®. For more information, please visit our website at www.marriott.com, and for the latest company news, visit www.marriottnewscenter.com. Connect with us on Facebook and @MarriottIntl on Twitter and Instagram.


News Article | May 15, 2017
Site: globenewswire.com

May is nationally recognized by the American Heart Association and the American Stroke Association as stroke awareness month. Stroke is a serious disease that ranks fifth in causes of death and disability when compared to heart disease, cancer, respiratory diseases and accidents. Most strokes are preventable and if treated quickly may make the difference between life and death - or the difference between a full recovery and long-term disability such as paralysis on one side of the body, speech or vision problems or memory loss. When a stroke happens, every second counts – as in the case of David Denmark. David, a 48 year-old homicide detective in Miami-Dade, was at a restaurant one evening when he experienced sudden stroke symptoms.  “All of a sudden I couldn’t move … I couldn’t open my eyes because of the vertigo…and then it went downhill fast, really fast,” he says. He was transported to Baptist Hospital’s Comprehensive Stroke Center where he was met by an expert team led by Sergio Jaramillo, M.D. “When Mr. Denmark entered the Center, we obtained a CT of the brain, assessed him neurologically and came up with a score that tells us how severe the neurological deficit is,” Dr. Jaramillo said, a neurologist with Baptist Health Neuroscience Center.  “If the patient presents within three hours, we can consider them a good candidate for TPA like Mr. Denmark.” TPA is a clot buster, a medicine that breaks up the clot wherever it may be. According to Dr. Jaramillo, David responded remarkably well and within 24 hours all of his neurological symptoms had resolved and there was no evidence he would have any permanent effect on his quality of life. “Every day I wake up and I can move freely. I constantly think what it could have been like. I know how lucky I am,” David says. Dr. Jaramillo goes on to say that “If he hadn’t come to our comprehensive stroke center, there likely would have been some kind of permanent neurological deficit and would have had a negative effect on his quality of life”. That’s why the Joint Commission, which accredits U.S. healthcare organizations, along with the American Heart Association and American Stroke Association, have maintained a unique alliance since 2003 to promote stroke care in hospitals across the nation. More than two years ago, Baptist Hospital in conjunction with Baptist Health Neuroscience Center, joined an elite group of facilities in the United States to be designated by the commission as a Comprehensive Stroke Center. The Joint Commission’s highest level of stroke care, an Advanced Certification, is awarded to those hospitals that have specific abilities to receive and treat the most complex stroke cases. To achieve its status as a Comprehensive Stroke Center, Baptist Hospital underwent a rigorous onsite review by Joint Commission experts. The hospital was shown to have the necessary requirements, including: This month, Baptist Hospital in conjunction with Baptist Health Neuroscience Center was awarded the American Heart Association/American Stroke Association’s top award: Get With The Guidelines®-Stroke Gold Plus Achievement Award with Target: StrokeSM Honor Roll Elite Plus. The award recognizes commitment to providing the most appropriate stroke treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence. Baptist Health Neuroscience Center offers comprehensive and innovative techniques to diagnose and treat the brain, spine and nervous system. Designated as a Comprehensive Stroke Center by The Joint Commission and the American Heart Association and the American Stroke Association, the Center’s philosophy is to provide the most effective care in the least invasive manner. Baptist Health Neuroscience Center is part of Baptist Health South Florida, the largest healthcare organization in the region, with seven hospitals (Baptist Hospital, Baptist Children’s Hospital, Doctors Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital), nearly 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence. A not-for-profit organization supported by philanthropy and committed to our faith-based charitable mission of medical excellence, Baptist Health has approximately 16,000 employees and 2,300 affiliated physicians. Baptist Health South Florida has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net and connect with us on Facebook at facebook.com/BaptistHealthSF and on Twitter and Instagram @BaptistHealthSF. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/abe1c9c9-32b0-45af-9300-37f685dc0625


News Article | May 15, 2017
Site: globenewswire.com

May is nationally recognized by the American Heart Association and the American Stroke Association as stroke awareness month. Stroke is a serious disease that ranks fifth in causes of death and disability when compared to heart disease, cancer, respiratory diseases and accidents. Most strokes are preventable and if treated quickly may make the difference between life and death - or the difference between a full recovery and long-term disability such as paralysis on one side of the body, speech or vision problems or memory loss. When a stroke happens, every second counts – as in the case of David Denmark. David, a 48 year-old homicide detective in Miami-Dade, was at a restaurant one evening when he experienced sudden stroke symptoms.  “All of a sudden I couldn’t move … I couldn’t open my eyes because of the vertigo…and then it went downhill fast, really fast,” he says. He was transported to Baptist Hospital’s Comprehensive Stroke Center where he was met by an expert team led by Sergio Jaramillo, M.D. “When Mr. Denmark entered the Center, we obtained a CT of the brain, assessed him neurologically and came up with a score that tells us how severe the neurological deficit is,” Dr. Jaramillo said, a neurologist with Baptist Health Neuroscience Center.  “If the patient presents within three hours, we can consider them a good candidate for TPA like Mr. Denmark.” TPA is a clot buster, a medicine that breaks up the clot wherever it may be. According to Dr. Jaramillo, David responded remarkably well and within 24 hours all of his neurological symptoms had resolved and there was no evidence he would have any permanent effect on his quality of life. “Every day I wake up and I can move freely. I constantly think what it could have been like. I know how lucky I am,” David says. Dr. Jaramillo goes on to say that “If he hadn’t come to our comprehensive stroke center, there likely would have been some kind of permanent neurological deficit and would have had a negative effect on his quality of life”. That’s why the Joint Commission, which accredits U.S. healthcare organizations, along with the American Heart Association and American Stroke Association, have maintained a unique alliance since 2003 to promote stroke care in hospitals across the nation. More than two years ago, Baptist Hospital in conjunction with Baptist Health Neuroscience Center, joined an elite group of facilities in the United States to be designated by the commission as a Comprehensive Stroke Center. The Joint Commission’s highest level of stroke care, an Advanced Certification, is awarded to those hospitals that have specific abilities to receive and treat the most complex stroke cases. To achieve its status as a Comprehensive Stroke Center, Baptist Hospital underwent a rigorous onsite review by Joint Commission experts. The hospital was shown to have the necessary requirements, including: This month, Baptist Hospital in conjunction with Baptist Health Neuroscience Center was awarded the American Heart Association/American Stroke Association’s top award: Get With The Guidelines®-Stroke Gold Plus Achievement Award with Target: StrokeSM Honor Roll Elite Plus. The award recognizes commitment to providing the most appropriate stroke treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence. Baptist Health Neuroscience Center offers comprehensive and innovative techniques to diagnose and treat the brain, spine and nervous system. Designated as a Comprehensive Stroke Center by The Joint Commission and the American Heart Association and the American Stroke Association, the Center’s philosophy is to provide the most effective care in the least invasive manner. Baptist Health Neuroscience Center is part of Baptist Health South Florida, the largest healthcare organization in the region, with seven hospitals (Baptist Hospital, Baptist Children’s Hospital, Doctors Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital), nearly 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence. A not-for-profit organization supported by philanthropy and committed to our faith-based charitable mission of medical excellence, Baptist Health has approximately 16,000 employees and 2,300 affiliated physicians. Baptist Health South Florida has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net and connect with us on Facebook at facebook.com/BaptistHealthSF and on Twitter and Instagram @BaptistHealthSF. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/abe1c9c9-32b0-45af-9300-37f685dc0625


News Article | May 15, 2017
Site: globenewswire.com

May is nationally recognized by the American Heart Association and the American Stroke Association as stroke awareness month. Stroke is a serious disease that ranks fifth in causes of death and disability when compared to heart disease, cancer, respiratory diseases and accidents. Most strokes are preventable and if treated quickly may make the difference between life and death - or the difference between a full recovery and long-term disability such as paralysis on one side of the body, speech or vision problems or memory loss. When a stroke happens, every second counts – as in the case of David Denmark. David, a 48 year-old homicide detective in Miami-Dade, was at a restaurant one evening when he experienced sudden stroke symptoms.  “All of a sudden I couldn’t move … I couldn’t open my eyes because of the vertigo…and then it went downhill fast, really fast,” he says. He was transported to Baptist Hospital’s Comprehensive Stroke Center where he was met by an expert team led by Sergio Jaramillo, M.D. “When Mr. Denmark entered the Center, we obtained a CT of the brain, assessed him neurologically and came up with a score that tells us how severe the neurological deficit is,” Dr. Jaramillo said, a neurologist with Baptist Health Neuroscience Center.  “If the patient presents within three hours, we can consider them a good candidate for TPA like Mr. Denmark.” TPA is a clot buster, a medicine that breaks up the clot wherever it may be. According to Dr. Jaramillo, David responded remarkably well and within 24 hours all of his neurological symptoms had resolved and there was no evidence he would have any permanent effect on his quality of life. “Every day I wake up and I can move freely. I constantly think what it could have been like. I know how lucky I am,” David says. Dr. Jaramillo goes on to say that “If he hadn’t come to our comprehensive stroke center, there likely would have been some kind of permanent neurological deficit and would have had a negative effect on his quality of life”. That’s why the Joint Commission, which accredits U.S. healthcare organizations, along with the American Heart Association and American Stroke Association, have maintained a unique alliance since 2003 to promote stroke care in hospitals across the nation. More than two years ago, Baptist Hospital in conjunction with Baptist Health Neuroscience Center, joined an elite group of facilities in the United States to be designated by the commission as a Comprehensive Stroke Center. The Joint Commission’s highest level of stroke care, an Advanced Certification, is awarded to those hospitals that have specific abilities to receive and treat the most complex stroke cases. To achieve its status as a Comprehensive Stroke Center, Baptist Hospital underwent a rigorous onsite review by Joint Commission experts. The hospital was shown to have the necessary requirements, including: This month, Baptist Hospital in conjunction with Baptist Health Neuroscience Center was awarded the American Heart Association/American Stroke Association’s top award: Get With The Guidelines®-Stroke Gold Plus Achievement Award with Target: StrokeSM Honor Roll Elite Plus. The award recognizes commitment to providing the most appropriate stroke treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence. Baptist Health Neuroscience Center offers comprehensive and innovative techniques to diagnose and treat the brain, spine and nervous system. Designated as a Comprehensive Stroke Center by The Joint Commission and the American Heart Association and the American Stroke Association, the Center’s philosophy is to provide the most effective care in the least invasive manner. Baptist Health Neuroscience Center is part of Baptist Health South Florida, the largest healthcare organization in the region, with seven hospitals (Baptist Hospital, Baptist Children’s Hospital, Doctors Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital), nearly 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence. A not-for-profit organization supported by philanthropy and committed to our faith-based charitable mission of medical excellence, Baptist Health has approximately 16,000 employees and 2,300 affiliated physicians. Baptist Health South Florida has been recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies. For more information, visit BaptistHealth.net and connect with us on Facebook at facebook.com/BaptistHealthSF and on Twitter and Instagram @BaptistHealthSF. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/abe1c9c9-32b0-45af-9300-37f685dc0625


LOS ANGELES--(BUSINESS WIRE)--Neural Analytics Inc., a medical device company developing and commercializing technology to measure, diagnose and track brain health, today announced initial results of the EXPEDITE clinical study showing its Transcranial Doppler Technology Platform under research, was more than 95 percent accurate for the early detection of acute ischemic stroke (AIS) due to large vessel occlusion (LVO). The data were presented at the 26th annual European Stroke Conference, taking place from May 24-26 in Berlin. “Current standard of care for stroke diagnosis can be expensive and time consuming, underscoring a significant unmet need for an improved method for first responders and ER physicians to rapidly and accurately assess and triage patients for appropriate clinical intervention,” said Thomas Devlin, MD, PhD, principal study investigator and Medical Director of Erlanger Health System’s Southeast Regional Stroke Center in Chattanooga, Tennessee. “These results show Neural Analytics’ portable diagnostic platform has the potential to fundamentally change how we detect stroke, and could lead to significantly improved patient outcomes as patients are more rapidly triaged for treatment.” The EXPEDITE study, conducted at Erlanger Health System, examined the effectiveness of Neural Analytics’ transcranial Doppler (TCD) platform in assessing patients for stroke. The research study evaluated 45 subjects either experiencing computed tomography angiography (CTA) confirmed Acute Ischemic Stroke due to Large Vessel Occlusion of the internal carotid artery (ICA) or middle cerebral artery (MCA) or matched healthy controls. TCD scans were recorded in 30 second intervals across multiple depths for each brain hemisphere while patients awaited treatment. Data were analyzed using two different stroke assessment algorithms. A Stroke Asymmetry Index (SAI) which compared depth matched bilateral scans and a Stroke Waveform Morphology Index (SMI) which used an algorithm to asses Doppler waveform morphology changes. Both methods were 96% accurate for assessing large vessel occlusion. “We are encouraged by these study results, demonstrating that under research our novel TCD platform may prove to bridge the significant gap in current stroke detection and management,” said Dr. Robert Hamilton, Chief Scientific Officer of Neural Analytics. “Today, fewer than 10 percent of eligible stroke patients are treated surgically due to the lack of a portable diagnostic device for early detection which would enable earlier stroke diagnoses for first responders and ER physicians.”1,2,4 Neural Analytics also announced the expansion of the EXPEDITE study, projected to enroll 140 patients, to Baptist Hospital in Jacksonville, Florida. Globally each year severe blood flow disorders affect more than 30 million people. Traumatic Brain Injury and stroke contribute the most to the global disease burden for these disorders. Stroke is the second most common cause of death in Europe and about 1.1 million die of stroke in Europe each year.1 Globally stroke affects about 16 million people and kills an estimated 5.7 million, with an annual U.S. healthcare cost of $104 billion.2,3,4,5 There are 14.8 million people affected by Traumatic Brain Injury globally each year, with 2.5 million in the United States. Neural Analytics’ Lucid M1 Transcranial Doppler Ultrasound System™ (Lucid System) is an all-in-one ultrasound system designed for measuring and displaying cerebral blood flow velocities and monitoring of patients with brain disorders. The Lucid System received its CE Mark in January of 2017. The company began selling the Lucid System in Europe in the first quarter of 2017 and opened its European office in Hamburg, Germany in April 2017. The Lucid System is a battery operated medical grade tablet device. It uses a type of ultrasound called Transcranial Doppler (TCD) to assess the brain’s blood vessels from outside the body. This analysis can be performed in the physician’s office, and can help the physician diagnose brain disorders, potentially without the need for additional, more invasive tests. Many significant brain disorders are caused by blood flow disruption. Neural Analytics was founded in 2013 to create products and services to measure, diagnose and track brain health. They combine leading data science with cutting edge hardware to allow first responders and clinicians to accurately assess and monitor brain health issues. Their devices are designed to be portable, autonomous, reliable, and produce precise and objective physiological measurements for medical responder monitoring of neural disorders. More information is available at http://www.neuralanalytics.com. 2. Ganesalingam, J. Cost Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke. Stroke. 2015 Sep;46(9):2591-8. doi: 10.1161/STROKEAHA.115.009396. Epub 2015 Aug 6. 3. Saver, J. et. Al. Stent Retriever Thrombectomy after Intraveneous t-PA vs. t_PA alone in stroke. N Engl J Med 2015; 372:2285-2295. 4. Ovbiagele, B. et. Al Forecasting the Future of Stroke in the United States. Stroke. 2013.


Miami Cancer Institute expects to be the primary destination for cancer patients in the southeastern United States, Latin America and the Caribbean. The center provides all cancer services under one roof. Besides the proton facility, Miami Cancer Institute hosts other front-line treatment modalities from Accuray, Elekta, Varian and ViewRay. The customer has chosen C-RAD’s SIGRT (Surface Image Guided Radiation Therapy) solution to optimize patient safety before and during treatment. Due to the precision of proton therapy in delivering radiation dose to the tumor, a high level of accuracy is required for patient positioning before and during treatment. The Catalyst™ system will be delivered with the complete software suite with modules for Respiratory Gating, Patient Setup and Positioning and Motion Monitoring. The C-RAD SIGRT solution provides a continuous monitoring of the patient during a treatment fraction. Patient motion above a clinically defined threshold will interrupt the treatment beam. C-RAD provides interfaces to seamlessly integrate its products into the workflow. In April 2015, C-RAD validated its respiratory gating interface for IBA proton and particle therapy. It is the intention to cooperate with Miami Cancer Institute to develop a dedicated clinical workflow for proton therapy. C-RAD Sentinel 4DCT is an easy-to-use, laser-based optical surface scanning system with functionality for 4D CT reconstruction and gated imaging in a CT room. It also provides reference images for patient positioning. Alonso N. Gutierrez, PhD, MBA, Chief of Medical Physics, from Miami Cancer Institute says: “We are excited to welcome this technology to our state-of-the-art proton center. Using the Catalyst HD system, we believe we will be able to improve our initial patient set up, monitor any patient motion during beam-on and gate the proton beam in an efficient manner to facilitate patient throughput.” “We are honored to work with the team from Miami Cancer Institute on this prestigious project. It is our intention to build-up this site as an international reference site in the proton therapy landscape.” says Tim Thurn, CEO and President of C-RAD AB, “The overall development within radiation therapy is encouraging for C-RAD. The demand for accurate patient positioning is continuously increasing, and I am confident that C-RAD will contribute to help cure more cancer patients with our cutting-edge solutions and as being a trusted partner to our customers.” The order amounts to a total of approximately 7,5 mSEK and includes the delivery of the systems and a service contract for a period of five years. Ít is expected to commence delivery and installation in the second quarter 2017. The project is booked as order intake in the second quarter 2017. Baptist Health is the largest healthcare organization in South Florida, with seven hospitals (Baptist Hospital, Baptist Children’s Hospital, Doctors Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital and West Kendall Baptist Hospital) and more than 30 outpatient and urgent care facilities spanning three counties. Not-for-profit, faith-based Baptist Health has more than 15,000 employees and 2,200 affiliated physicians, and also includes Baptist Heath Medical Group, Baptist Outpatient Services and internationally renowned centers of excellence. Baptist Health Foundation, the organization’s fundraising arm, supports services at all hospitals and facilities. Baptist Health is listed by Fortune magazine as one of the 100 Best Companies to Work for in America (No. 23 in the nation) and has remained on the list for 15 years. It is also recognized as one of the World’s Most Ethical Companies for the fifth year in a row by Ethisphere Institute. C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm. For more information on C-RAD, please visit http://www.c-rad.com This information is information that C-RAD AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 08:30 CET on April 18, 2017.

Loading Baptist Hospital collaborators
Loading Baptist Hospital collaborators